TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-019843-20

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- To evaluate the durability of sustained virologic response (SVR) in subjects who were treated with a TMC435- containing regimen in a previous Phase IIb or Phase III study and maintained undetectable HCV ribonucleic acid (RNA) until the last planned visit of that previous study (LPVPS). - To evaluate sequence changes in the HCV NS3/4A region over time in subjects who were treated with a TMC435-containing regimen in a previous Phase IIb or Phase III study and had confirmed detectable HCV RNA at the LPVPS.


Critère d'inclusion

  • Hepatitis C virus (HCV)